NAMS - NewAmsterdam Pharma Company NV Dividends

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: MDGL VKTX RYTM BMRN AXSM KRYS ALNY INCY KROS NBIX

| Held by: CGMM IBB VHT SBIO ESML ONEQ FHLC DRKY GURU MSSM

Scroll to Statements

Index	-
Market Cap	3.19B
Enterprise Value	2.56B
Income	-212.73M
Sales	22.57M
Book/sh	5.70
Cash/sh	5.45
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	100
IPO	Feb 08, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	141.51
P/B	4.79
P/C	5.01
P/FCF	-
EV/EBITDA	-
EV/Sales	113.27
Quick Ratio	9.76
Current Ratio	9.76
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-1.80
EPS next Y	-1.35
EPS next Q	-0.47
EPS this Y	-3.18%
EPS next Y	24.06%
EPS next 5Y	47.88%
EPS past 3/5Y	-12.98% -
Sales past 3/5Y	-39.71% -
EPS Y/Y TTM	3.91%
Sales Y/Y TTM	-52.13%
EPS Q/Q	-16.92%
Sales Q/Q	2.08%
Earnings	May 07 BMO
EPS/Sales Surpr.	12.42% 73.38%

Insider Own	31.51%
Insider Trans	-3.61%
Inst Own	72.86%
Inst Trans	-2.32%
ROA	-27.43%
ROE	-29.49%
ROIC	-31.98%
Gross Margin	98.98%
Oper. Margin	-953.59%
Profit Margin	-942.76%
SMA20	-11.78%
SMA50	-14.51%
SMA200	-19.01%
Trades

Shs Outstand	116.64M
Shs Float	80.07M
Short Float	11.46%
Short Ratio	7.11
Short Interest	9.18M
52W High	42.21 -35.27%
52W Low	21.23 28.67%
Volatility	6.08% 5.97%
ATR (14)	1.72
RSI (14)	34.84
Beta	0.11
Rel Volume	0.48
Avg Volume	1.29M
Volume	503,804

Perf Week	-2.35%
Perf Month	-21.72%
Perf Quarter	-8.50%
Perf Half Y	-13.46%
Perf YTD	-22.12%
Perf Year	26.14%
Perf 3Y	155.82%
Perf 5Y	181.08%
Perf 10Y	-
Recom	1.12
Target Price	51.93
Prev Close	27.49
Price	27.32
Change	-0.61%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)